Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 602

The DOI matches its Crossref record.

Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients: A single‐institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and end results database

Morris, Gloria J., Naidu, Sashi, Topham, Allan K., Guiles, Fran, Xu, Yihuan, McCue, Peter, Schwartz, Gordon F., Park, Pauline K., Rosenberg, Anne L., Brill, Kristin, Mitchell, Edith P.·2007·Cancer

Abstract

BACKGROUND: Breast carcinomas in African–American patients appear to be more aggressive than in Caucasian patients due to multifactorial differences. METHODS: The authors compiled pathology data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database regarding stage, histologic grade, and estrogen receptor (ER) expression in breast carcinomas diagnosed in 197,274 African–American and Caucasian patients between 1990 and 2000, and the same information, along with nuclear grade, Ki‐67, c‐erb‐B2, and p53 expression, in 2230 African–American and Caucasian patients diagnosed at Thomas Jefferson University Hospital between 1995 and 2002. Immunohistochemical markers were assayed in paraffin‐embedded, formalin‐fixed tissue stained with hematoxylin and eosin using antibodies to these proteins, with differences in expression analyzed by the chisquare test. RESULTS: In both databases, more African–American patients presented with advanced stage tumors and higher histologic (P < .001) and nuclear grade (P < .001) than Caucasian patients. African–American patients had less ER positivity (51.9% vs 63.1%; P < .001) but significantly higher Ki‐67 (42.4% vs 28.7%; P < .001) and p53 expression (19.4% vs 13.1%; P < .05) than Caucasian patients with all stages of disease. In addition, the basal or “triple‐negative” breast cancer phenotype was more common in African–American patients than in Caucasian patients (20.8% vs 10.4%; P < .0001), and was associated with higher histologic and nuclear grade (P < .0001). CONCLUSIONS: African–American patients with breast carcinomas are more likely than Caucasian patients to present with tumors that are of a later stage and higher grade, with higher Ki‐67 expression and more ER negativity, thereby highlighting a greater need for early screening among African–American women. Molecular studies that may explain these differences, and correlations with survival, have been proposed to identify therapeutic targets. Cancer 2007. © 2007 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22836

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 602

Metadata

Authors
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., & Mitchell, E. P.
Venue
Cancer
Publisher
Wiley
Published
2007-07-09
Volume
110
Issue
4
Pages
876-884
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1839791863
Cited by
602
References
0
FWCI
9.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients: A single‐institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and end results database. https://app.cochat.ai/papers/10.1002/cncr.22836
The paper
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., & Mitchell, E. P. (2007). Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients: A single‐institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and end results database. Cancer. https://doi.org/10.1002/cncr.22836

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.